<DOC>
	<DOCNO>NCT00002291</DOCNO>
	<brief_summary>To evaluate compare safety , tolerability , efficacy biweekly administration 1 3 dos aerosol pentamidine use prophylactic agent patient recover first episode AIDS-associated Pneumocystis carinii pneumonia ( PCP ) .</brief_summary>
	<brief_title>The Safety Effectiveness Pentamidine Prevention Pneumocystis Carinii Pneumonia ( PCP ) Patients With AIDS Who Have Had PCP Before</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Pneumocystis</mesh_term>
	<mesh_term>Pentamidine</mesh_term>
	<criteria>Inclusion Criteria Concurrent Medication : Allowed : Zidovudine ( AZT ) . Exclusion Criteria Coexisting Condition : Patients follow exclude : Requiring ongoing active therapy opportunistic infection ( O.I . ) time entry either follow AIDSdefining O.I . 's prior entry : Toxoplasmosis . Cryptococcosis . Transfusion dependent ( require blood transfusion per month ) . The last transfusion give within 7 day study entry . Pulmonary Kaposi 's sarcoma ( KS ) . Asthma require medication . Active therapy tuberculosis . Concurrent Medication : Excluded : Active therapy tuberculosis . Patients follow exclude : Requiring ongoing active therapy opportunistic infection ( O.I . ) time entry either follow AIDSdefining O.I . 's prior entry : Toxoplasmosis . Cryptococcosis . Transfusion dependent ( require blood transfusion per month ) . The last transfusion give within 7 day study entry . Pulmonary Kaposi 's sarcoma ( KS ) . Unwilling sign inform consent . Can cooperate study procedure . Asthma require medication . Prior Medication : Excluded within 30 day study entry : Antiretrovirals zidovudine ( AZT ) . Immunomodulating agent . Corticosteroids . Patients must : Have AIDS recover first episode cytologically histologically proven Pneumocystis carinii pneumonia ( PCP ) . Be least 2 week 24 week status post therapy acute PCP . Have positive antibody HIV federally license ELISA test kit , confirm Western blot test . Have adequate pulmonary function ( vital capacity = &gt; 80 percent predict ; force expiratory volume ( FEV ) , 1 = &gt; 65 percent total FEV ; correct pulmonary diffusion capacity &gt; 60 percent predict ) . Free acute medical problem . Active substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 1989</verification_date>
	<keyword>AIDS-Related Opportunistic Infections</keyword>
	<keyword>Pneumonia , Pneumocystis carinii</keyword>
	<keyword>Pentamidine</keyword>
	<keyword>Dose-Response Relationship , Drug</keyword>
	<keyword>Aerosols</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
</DOC>